Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000032:analysis; D000469:Alkaline Phosphatase / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000032:analysis; D001663:Bilirubin / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D004977:Ethambutol / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011859:Radiography; D012293:Rifampin / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000201:enzymology / Q000382:microbiology / Q000503:physiopathology
D006454:Hemoglobins; D004977:Ethambutol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005000:Ethionamide; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin